A systematic review and meta-analysis of animal studies investigating the relationship between serum antibody, T lymphocytes, and respiratory syncytial virus disease

A systematic review and meta-analysis of animal studies investigating the relationship between serum antibody, T lymphocytes, and respiratory syncytial virus disease

<p><strong>Background</strong></p> Respiratory syncytial virus (RSV) infections occur in human populations around the globe, causing disease of variable severity, disproportionately affecting infants and older adults (>65 years of age). Immune responses can be protective b...

ver descrição completa

Detalhes bibliográficos
Main Authors:	McGinley, J, Thwaites, R, Brebner, W, Greenan-Barrett, L, Aerssens, J, Öner, D, Bont, L, Wildenbeest, J, Martinón-Torres, F, Nair, H, Pollard, AJ, Openshaw, P, Drysdale, S
Outros Autores:	REspiratory Syncytial virus Consortium in EUrope (RESCEU) Investigators
Formato:	Journal article
Idioma:	English
Publicado em:	Oxford University Press 2021

Registos relacionados

Clinical and viral factors associated with disease severity and subsequent wheezing in infants with respiratory syncytial virus infection
Por: McGinley, JP, et al.
Publicado em: (2022)

Single-cell immune profiling reveals markers of emergency myelopoiesis that distinguish severe from mild respiratory syncytial virus disease in infants
Por: Zivanovic, N, et al.
Publicado em: (2023)

A genome-wide association study of respiratory syncytial virus infection severity in infants
Por: Johnson, M, et al.
Publicado em: (2024)

Single‐cell immune profiling reveals markers of emergency myelopoiesis that distinguish severe from mild respiratory syncytial virus disease in infants
Por: Nevena Zivanovic, et al.
Publicado em: (2023-12-01)

Presumed risk factors and biomarkers for severe respiratory syncytial virus disease and related sequelae: Protocol for an observational multicenter, case-control study from the Respiratory Syncytial Virus Consortium in Europe (RESCEU)
Por: Jefferies, K, et al.
Publicado em: (2020)

T cells, more than antibodies, may prevent symptoms developing from respiratory syncytial virus infections in older adults
Por: Salaun, B, et al.
Publicado em: (2023)

Simultaneous viral whole-genome sequencing and differential expression profiling in respiratory syncytial virus infection of infants
Por: Lin, G-L, et al.
Publicado em: (2020)

Transcriptomic analysis of biomarkers of respiratory syncytial virus disease
Por: McGinley, J
Publicado em: (2020)

External validation of the discriminative validity of the ReSVinet score & development of simplified ReSVinet scores in secondary care
Por: Sheikh, Z, et al.
Publicado em: (2023)

Biomarkers for disease severity in children infected with respiratory syncytial virus: a systematic literature review
Por: Öner, D, et al.
Publicado em: (2020)

Serum and mucosal antibody-mediated protection and identification of asymptomatic respiratory syncytial virus infection in community-dwelling older adults in Europe
Por: Öner, D, et al.
Publicado em: (2024)

Distinct patterns of within-host virus populations between two subgroups of human respiratory syncytial virus
Por: Lin, G-L, et al.
Publicado em: (2021)

Immunological and inflammatory biomarkers of susceptibility and severity in adult respiratory syncytial virus infections
Por: Wiseman, DJ, et al.
Publicado em: (2020)

T cells, more than antibodies, may prevent symptoms developing from respiratory syncytial virus infections in older adults
Por: Bruno Salaun, et al.
Publicado em: (2023-10-01)

Targeted metagenomics reveals association between severity and pathogen co-detection in infants with respiratory syncytial virus
Por: Lin, G-L, et al.
Publicado em: (2024)

Vaccination against respiratory syncytial virus
Por: Green, CA, et al.
Publicado em: (2020)

Year-to-year variation in attack rates could result in underpowered respiratory syncytial virus vaccine efficacy trials
Por: Billard, MN, et al.
Publicado em: (2022)

Respiratory Syncytial Virus Consortium in Europe (RESCEU) birth cohort study: defining the burden of infant respiratory syncytial virus disease in Europe
Por: Wildenbeest, JG, et al.
Publicado em: (2020)

Burden of respiratory syncytial virus infection in community-dwelling older adults in Europe (RESCEU): an international prospective cohort study
Por: Korsten, K, et al.
Publicado em: (2021)

Distinct patterns of within-host virus populations between two subgroups of human respiratory syncytial virus
Por: Gu-Lung Lin, et al.
Publicado em: (2021-08-01)

Publisher Correction: Distinct patterns of within-host virus populations between two subgroups of human respiratory syncytial virus
Por: Gu-Lung Lin, et al.
Publicado em: (2021-10-01)

Mucosal Immune Responses to Respiratory Syncytial Virus
Por: Megan V. C. Barnes, et al.
Publicado em: (2022-03-01)

The burden of respiratory syncytial virus in healthy term-born infants in Europe: a prospective birth cohort study
Por: Wildenbeest, JG, et al.
Publicado em: (2022)

Serum and mucosal antibody-mediated protection and identification of asymptomatic respiratory syncytial virus infection in community-dwelling older adults in Europe
Por: Deniz Öner, et al.
Publicado em: (2024-10-01)

Targeted metagenomics reveals association between severity and pathogen co-detection in infants with respiratory syncytial virus
Por: Gu-Lung Lin, et al.
Publicado em: (2024-03-01)

Airway and blood monocyte transcriptomic profiling reveals an antiviral phenotype in infants with severe respiratory syncytial virus infection
Por: Chappin, K, et al.
Publicado em: (2024)

Antibody-mediated protection against respiratory syncytial virus in children
Por: Emma L. Coindy, et al.
Publicado em: (2024-10-01)

Epidemiology and immune pathogenesis of viral sepsis
Por: Lin, G, et al.
Publicado em: (2018)

Economic burden and health-related quality-of-life among infants with respiratory syncytial virus infection: a multi-country prospective cohort study in Europe
Por: Mao, Z, et al.
Publicado em: (2023)

Respiratory syncytial virus: Immunisation and prophylaxis
Por: Barr, R, et al.
Publicado em: (2018)

Management of Respiratory Syncytial Virus Bronchiolitis: 2015 Survey of Members of the European Society for Paediatric Infectious Diseases
Por: Elliott J. Carande, et al.
Publicado em: (2016-01-01)

Unveiling the risk period for death after respiratory syncytial virus Illness in young children using a self- controlled case series design
Por: Li, Y, et al.
Publicado em: (2020)

Management of respiratory syncytial virus bronchiolitis: 2015 survey of members of the European Society for Paediatric Infectious Disease
Por: Drysdale, S, et al.
Publicado em: (2016)

Priorities for developing respiratory syncytial virus (RSV) vaccines in different target populations
Por: Drysdale, S, et al.
Publicado em: (2020)

Seasonal immunisation against respiratory syncytial virus disease
Por: Koos Korsten, et al.
Publicado em: (2017-08-01)

Potential therapeutic implications of new insights into respiratory syncytial virus disease
Por: Openshaw Peter JM
Publicado em: (2002-06-01)

Respiratory syncytial virus: diagnosis, prevention and management
Por: Barr, R, et al.
Publicado em: (2019)

Epidemiology and Immune Pathogenesis of Viral Sepsis
Por: Gu-Lung Lin, et al.
Publicado em: (2018-09-01)

Airway response to respiratory syncytial virus has incidental antibacterial effects
Por: Sande, C, et al.
Publicado em: (2019)

Th17 Lymphocytes in Respiratory Syncytial Virus Infection
Por: Rizgar A. Mageed, et al.
Publicado em: (2013-03-01)